Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages

Zoledronic acid (ZA) has been tested in clinical trials as an additive therapy for early-stage breast cancer. However, the mechanism by which ZA exerts its antitumor activity is still unclear. The aim of this study is to investigate whether the prevention of tumor growth by ZA is through regulating...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Xiao-Hua, Du, Yang, Mao, Duo, Wang, Zhong-Liang, He, Zhen-Qiang, Qiu, Jing-Dan, Ma, Xi-Bo, Shang, Wen-Ting, Ding, Dan, Tian, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694882/
https://www.ncbi.nlm.nih.gov/pubmed/26305552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694882/
https://www.ncbi.nlm.nih.gov/pubmed/26305552

Ejemplares similares